nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A5—Dactinomycin—sarcoma	0.237	0.457	CbGbCtD
Epinephrine—CYP1A2—Dacarbazine—sarcoma	0.0794	0.153	CbGbCtD
Epinephrine—CYP3A4—Thiotepa—sarcoma	0.0751	0.145	CbGbCtD
Epinephrine—CYP1A2—Etoposide—sarcoma	0.0388	0.0748	CbGbCtD
Epinephrine—CYP3A4—Mitoxantrone—sarcoma	0.0323	0.0622	CbGbCtD
Epinephrine—CYP3A4—Vincristine—sarcoma	0.0222	0.0428	CbGbCtD
Epinephrine—CYP3A4—Etoposide—sarcoma	0.0204	0.0392	CbGbCtD
Epinephrine—CYP3A4—Doxorubicin—sarcoma	0.0139	0.0267	CbGbCtD
Epinephrine—Ischaemia—Mitoxantrone—sarcoma	0.00671	0.0278	CcSEcCtD
Epinephrine—Tachyarrhythmia—Epirubicin—sarcoma	0.00625	0.0259	CcSEcCtD
Epinephrine—Skin necrosis—Etoposide—sarcoma	0.00582	0.0241	CcSEcCtD
Epinephrine—Tachyarrhythmia—Doxorubicin—sarcoma	0.00578	0.0239	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Thiotepa—sarcoma	0.00512	0.0212	CcSEcCtD
Epinephrine—Lactic acidosis—Epirubicin—sarcoma	0.00467	0.0194	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Vincristine—sarcoma	0.00454	0.0188	CcSEcCtD
Epinephrine—Local reaction—Mitoxantrone—sarcoma	0.00442	0.0183	CcSEcCtD
Epinephrine—ADRBK1—mammary gland—sarcoma	0.00438	0.0829	CbGeAlD
Epinephrine—Lactic acidosis—Doxorubicin—sarcoma	0.00432	0.0179	CcSEcCtD
Epinephrine—Nephropathy—Etoposide—sarcoma	0.00427	0.0177	CcSEcCtD
Epinephrine—Memory impairment—Thiotepa—sarcoma	0.00361	0.015	CcSEcCtD
Epinephrine—Necrosis—Dactinomycin—sarcoma	0.00358	0.0148	CcSEcCtD
Epinephrine—PAH—hematopoietic system—sarcoma	0.0035	0.0662	CbGeAlD
Epinephrine—Skin necrosis—Epirubicin—sarcoma	0.00326	0.0135	CcSEcCtD
Epinephrine—Extravasation—Thiotepa—sarcoma	0.00325	0.0135	CcSEcCtD
Epinephrine—Extravasation—Dactinomycin—sarcoma	0.00322	0.0134	CcSEcCtD
Epinephrine—Hemiplegia—Epirubicin—sarcoma	0.00319	0.0132	CcSEcCtD
Epinephrine—Necrosis—Mitoxantrone—sarcoma	0.00312	0.0129	CcSEcCtD
Epinephrine—Myocardial ischaemia—Mitoxantrone—sarcoma	0.00304	0.0126	CcSEcCtD
Epinephrine—Skin necrosis—Doxorubicin—sarcoma	0.00302	0.0125	CcSEcCtD
Epinephrine—ADRBK1—embryo—sarcoma	0.00299	0.0566	CbGeAlD
Epinephrine—Hemiplegia—Doxorubicin—sarcoma	0.00296	0.0122	CcSEcCtD
Epinephrine—Extravasation—Vincristine—sarcoma	0.00288	0.0119	CcSEcCtD
Epinephrine—Extravasation—Mitoxantrone—sarcoma	0.0028	0.0116	CcSEcCtD
Epinephrine—Contusion—Mitoxantrone—sarcoma	0.0028	0.0116	CcSEcCtD
Epinephrine—Drug interaction—Vincristine—sarcoma	0.00271	0.0112	CcSEcCtD
Epinephrine—Skin exfoliation—Thiotepa—sarcoma	0.0027	0.0112	CcSEcCtD
Epinephrine—ADRBK1—hematopoietic system—sarcoma	0.00267	0.0505	CbGeAlD
Epinephrine—ADRB3—connective tissue—sarcoma	0.00263	0.0498	CbGeAlD
Epinephrine—Necrosis—Etoposide—sarcoma	0.00259	0.0107	CcSEcCtD
Epinephrine—Tingling sensation—Etoposide—sarcoma	0.00253	0.0105	CcSEcCtD
Epinephrine—Pulmonary oedema—Thiotepa—sarcoma	0.00252	0.0104	CcSEcCtD
Epinephrine—ADRBK1—smooth muscle tissue—sarcoma	0.00235	0.0445	CbGeAlD
Epinephrine—Extravasation—Etoposide—sarcoma	0.00233	0.00966	CcSEcCtD
Epinephrine—Local reaction—Epirubicin—sarcoma	0.00206	0.00854	CcSEcCtD
Epinephrine—Skin exfoliation—Etoposide—sarcoma	0.00194	0.00805	CcSEcCtD
Epinephrine—Local reaction—Doxorubicin—sarcoma	0.00191	0.0079	CcSEcCtD
Epinephrine—ADRBK1—lymphoid tissue—sarcoma	0.00188	0.0356	CbGeAlD
Epinephrine—TNF—lymph node—sarcoma	0.00185	0.0349	CbGeAlD
Epinephrine—PAH—liver—sarcoma	0.00181	0.0343	CbGeAlD
Epinephrine—ADRBK1—bone marrow—sarcoma	0.00171	0.0324	CbGeAlD
Epinephrine—Hypokalaemia—Mitoxantrone—sarcoma	0.00162	0.0067	CcSEcCtD
Epinephrine—Hyperglycaemia—Thiotepa—sarcoma	0.0016	0.00664	CcSEcCtD
Epinephrine—Renal failure—Thiotepa—sarcoma	0.00156	0.00645	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Epirubicin—sarcoma	0.00154	0.00638	CcSEcCtD
Epinephrine—Sweating increased—Mitoxantrone—sarcoma	0.0015	0.00619	CcSEcCtD
Epinephrine—ADRBK1—testis—sarcoma	0.00146	0.0277	CbGeAlD
Epinephrine—Necrosis—Epirubicin—sarcoma	0.00145	0.00602	CcSEcCtD
Epinephrine—Haemoglobin—Thiotepa—sarcoma	0.00143	0.00592	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00143	0.00591	CcSEcCtD
Epinephrine—Haemorrhage—Thiotepa—sarcoma	0.00142	0.00589	CcSEcCtD
Epinephrine—Hallucination—Thiotepa—sarcoma	0.00142	0.00586	CcSEcCtD
Epinephrine—Acute coronary syndrome—Vincristine—sarcoma	0.00139	0.00574	CcSEcCtD
Epinephrine—Hyperglycaemia—Mitoxantrone—sarcoma	0.00138	0.00574	CcSEcCtD
Epinephrine—Myocardial infarction—Vincristine—sarcoma	0.00138	0.00571	CcSEcCtD
Epinephrine—Drowsiness—Mitoxantrone—sarcoma	0.00137	0.00567	CcSEcCtD
Epinephrine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00135	0.00559	CcSEcCtD
Epinephrine—Sweating—Vincristine—sarcoma	0.00135	0.00558	CcSEcCtD
Epinephrine—Renal failure—Mitoxantrone—sarcoma	0.00135	0.00557	CcSEcCtD
Epinephrine—Necrosis—Doxorubicin—sarcoma	0.00134	0.00557	CcSEcCtD
Epinephrine—Myocardial infarction—Mitoxantrone—sarcoma	0.00134	0.00556	CcSEcCtD
Epinephrine—SLC22A5—mammary gland—sarcoma	0.00132	0.025	CbGeAlD
Epinephrine—Sweating—Mitoxantrone—sarcoma	0.00131	0.00544	CcSEcCtD
Epinephrine—Flushing—Dactinomycin—sarcoma	0.00131	0.00543	CcSEcCtD
Epinephrine—Extravasation—Epirubicin—sarcoma	0.00131	0.00542	CcSEcCtD
Epinephrine—Arrhythmia—Thiotepa—sarcoma	0.00127	0.00527	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Epirubicin—sarcoma	0.00126	0.00523	CcSEcCtD
Epinephrine—Hypoaesthesia—Vincristine—sarcoma	0.00126	0.0052	CcSEcCtD
Epinephrine—Hallucination—Vincristine—sarcoma	0.00126	0.0052	CcSEcCtD
Epinephrine—Mental disorder—Thiotepa—sarcoma	0.00125	0.00516	CcSEcCtD
Epinephrine—Sweating increased—Etoposide—sarcoma	0.00124	0.00515	CcSEcCtD
Epinephrine—Erythema—Thiotepa—sarcoma	0.00124	0.00513	CcSEcCtD
Epinephrine—Haemoglobin—Mitoxantrone—sarcoma	0.00123	0.00512	CcSEcCtD
Epinephrine—Erythema—Dactinomycin—sarcoma	0.00123	0.00509	CcSEcCtD
Epinephrine—Haemorrhage—Mitoxantrone—sarcoma	0.00123	0.00509	CcSEcCtD
Epinephrine—Tension—Thiotepa—sarcoma	0.00122	0.00503	CcSEcCtD
Epinephrine—Extravasation—Doxorubicin—sarcoma	0.00121	0.00501	CcSEcCtD
Epinephrine—Nervousness—Thiotepa—sarcoma	0.0012	0.00498	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Doxorubicin—sarcoma	0.00117	0.00484	CcSEcCtD
Epinephrine—Agitation—Thiotepa—sarcoma	0.00114	0.00472	CcSEcCtD
Epinephrine—CYP2C9—mammary gland—sarcoma	0.00114	0.0215	CbGeAlD
Epinephrine—Acute coronary syndrome—Etoposide—sarcoma	0.00112	0.00465	CcSEcCtD
Epinephrine—Renal failure—Etoposide—sarcoma	0.00112	0.00464	CcSEcCtD
Epinephrine—Myocardial infarction—Etoposide—sarcoma	0.00112	0.00462	CcSEcCtD
Epinephrine—Mental disorder—Vincristine—sarcoma	0.00111	0.00458	CcSEcCtD
Epinephrine—Arrhythmia—Mitoxantrone—sarcoma	0.0011	0.00455	CcSEcCtD
Epinephrine—Skin exfoliation—Epirubicin—sarcoma	0.00109	0.00451	CcSEcCtD
Epinephrine—ADRB1—connective tissue—sarcoma	0.00108	0.0203	CbGeAlD
Epinephrine—Erythema—Mitoxantrone—sarcoma	0.00107	0.00443	CcSEcCtD
Epinephrine—Hypertension—Thiotepa—sarcoma	0.00107	0.00443	CcSEcCtD
Epinephrine—ADRBK1—lymph node—sarcoma	0.00106	0.0201	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00105	0.00434	CcSEcCtD
Epinephrine—Hypoaesthesia—Etoposide—sarcoma	0.00102	0.00421	CcSEcCtD
Epinephrine—Pulmonary oedema—Epirubicin—sarcoma	0.00102	0.00421	CcSEcCtD
Epinephrine—Agitation—Vincristine—sarcoma	0.00101	0.00418	CcSEcCtD
Epinephrine—Skin exfoliation—Doxorubicin—sarcoma	0.00101	0.00417	CcSEcCtD
Epinephrine—Nervous system disorder—Thiotepa—sarcoma	0.000991	0.00411	CcSEcCtD
Epinephrine—Tachycardia—Thiotepa—sarcoma	0.000987	0.00409	CcSEcCtD
Epinephrine—Skin disorder—Thiotepa—sarcoma	0.000982	0.00407	CcSEcCtD
Epinephrine—ADRA2C—myometrium—sarcoma	0.00098	0.0185	CbGeAlD
Epinephrine—Flushing—Etoposide—sarcoma	0.000949	0.00393	CcSEcCtD
Epinephrine—Hypertension—Vincristine—sarcoma	0.000948	0.00393	CcSEcCtD
Epinephrine—Pulmonary oedema—Doxorubicin—sarcoma	0.00094	0.00389	CcSEcCtD
Epinephrine—SLC22A5—myometrium—sarcoma	0.000939	0.0178	CbGeAlD
Epinephrine—Hypertension—Mitoxantrone—sarcoma	0.000923	0.00383	CcSEcCtD
Epinephrine—Chest pain—Mitoxantrone—sarcoma	0.000911	0.00377	CcSEcCtD
Epinephrine—Paraesthesia—Thiotepa—sarcoma	0.000908	0.00376	CcSEcCtD
Epinephrine—Somnolence—Thiotepa—sarcoma	0.000899	0.00372	CcSEcCtD
Epinephrine—ADRA2C—seminal vesicle—sarcoma	0.000886	0.0168	CbGeAlD
Epinephrine—ADRA1A—hematopoietic system—sarcoma	0.000883	0.0167	CbGeAlD
Epinephrine—Nervous system disorder—Vincristine—sarcoma	0.000879	0.00364	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000873	0.00362	CcSEcCtD
Epinephrine—Renal impairment—Epirubicin—sarcoma	0.00087	0.0036	CcSEcCtD
Epinephrine—Hyperhidrosis—Vincristine—sarcoma	0.000867	0.00359	CcSEcCtD
Epinephrine—Tachycardia—Mitoxantrone—sarcoma	0.000852	0.00353	CcSEcCtD
Epinephrine—Hypoglycaemia—Epirubicin—sarcoma	0.000849	0.00352	CcSEcCtD
Epinephrine—SLC22A5—seminal vesicle—sarcoma	0.000848	0.016	CbGeAlD
Epinephrine—ADRB1—cardiac atrium—sarcoma	0.000848	0.016	CbGeAlD
Epinephrine—Skin disorder—Mitoxantrone—sarcoma	0.000848	0.00351	CcSEcCtD
Epinephrine—Cerebrovascular accident—Epirubicin—sarcoma	0.000845	0.0035	CcSEcCtD
Epinephrine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000844	0.0035	CcSEcCtD
Epinephrine—Insomnia—Vincristine—sarcoma	0.000811	0.00336	CcSEcCtD
Epinephrine—Renal impairment—Doxorubicin—sarcoma	0.000805	0.00334	CcSEcCtD
Epinephrine—Paraesthesia—Vincristine—sarcoma	0.000805	0.00333	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—sarcoma	0.000785	0.00325	CcSEcCtD
Epinephrine—Paraesthesia—Mitoxantrone—sarcoma	0.000784	0.00325	CcSEcCtD
Epinephrine—ADRA2A—myometrium—sarcoma	0.000782	0.0148	CbGeAlD
Epinephrine—Cerebrovascular accident—Doxorubicin—sarcoma	0.000782	0.00324	CcSEcCtD
Epinephrine—Somnolence—Mitoxantrone—sarcoma	0.000776	0.00321	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vincristine—sarcoma	0.000774	0.00321	CcSEcCtD
Epinephrine—Hypertension—Etoposide—sarcoma	0.000768	0.00318	CcSEcCtD
Epinephrine—Chest pain—Etoposide—sarcoma	0.000757	0.00314	CcSEcCtD
Epinephrine—Hypokalaemia—Epirubicin—sarcoma	0.000754	0.00312	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000752	0.00312	CcSEcCtD
Epinephrine—CYP1A2—hematopoietic system—sarcoma	0.00073	0.0138	CbGeAlD
Epinephrine—Tachycardia—Etoposide—sarcoma	0.000709	0.00294	CcSEcCtD
Epinephrine—ADRA2A—seminal vesicle—sarcoma	0.000707	0.0134	CbGeAlD
Epinephrine—Skin disorder—Etoposide—sarcoma	0.000705	0.00292	CcSEcCtD
Epinephrine—Hyperhidrosis—Etoposide—sarcoma	0.000702	0.00291	CcSEcCtD
Epinephrine—SLC22A5—skin of body—sarcoma	0.000701	0.0133	CbGeAlD
Epinephrine—Hypokalaemia—Doxorubicin—sarcoma	0.000697	0.00289	CcSEcCtD
Epinephrine—CYP2C9—hematopoietic system—sarcoma	0.000693	0.0131	CbGeAlD
Epinephrine—ADRA2A—hematopoietic system—sarcoma	0.000672	0.0127	CbGeAlD
Epinephrine—Dizziness—Thiotepa—sarcoma	0.000668	0.00277	CcSEcCtD
Epinephrine—Paraesthesia—Etoposide—sarcoma	0.000652	0.0027	CcSEcCtD
Epinephrine—ADRA2A—connective tissue—sarcoma	0.000647	0.0122	CbGeAlD
Epinephrine—Hyperglycaemia—Epirubicin—sarcoma	0.000646	0.00267	CcSEcCtD
Epinephrine—Somnolence—Etoposide—sarcoma	0.000645	0.00267	CcSEcCtD
Epinephrine—Vomiting—Thiotepa—sarcoma	0.000643	0.00266	CcSEcCtD
Epinephrine—ADRA2C—cardiac atrium—sarcoma	0.000639	0.0121	CbGeAlD
Epinephrine—Drowsiness—Epirubicin—sarcoma	0.000638	0.00264	CcSEcCtD
Epinephrine—Vomiting—Dactinomycin—sarcoma	0.000638	0.00264	CcSEcCtD
Epinephrine—ADRA2C—uterus—sarcoma	0.000636	0.012	CbGeAlD
Epinephrine—Renal failure—Epirubicin—sarcoma	0.000627	0.0026	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Etoposide—sarcoma	0.000627	0.0026	CcSEcCtD
Epinephrine—ADRA1A—lymphoid tissue—sarcoma	0.000622	0.0118	CbGeAlD
Epinephrine—SLC22A5—cardiac atrium—sarcoma	0.000612	0.0116	CbGeAlD
Epinephrine—Sweating—Epirubicin—sarcoma	0.000612	0.00253	CcSEcCtD
Epinephrine—SLC22A1—liver—sarcoma	0.000601	0.0114	CbGeAlD
Epinephrine—Nausea—Thiotepa—sarcoma	0.0006	0.00249	CcSEcCtD
Epinephrine—Hyperglycaemia—Doxorubicin—sarcoma	0.000597	0.00247	CcSEcCtD
Epinephrine—Nausea—Dactinomycin—sarcoma	0.000596	0.00247	CcSEcCtD
Epinephrine—Dizziness—Vincristine—sarcoma	0.000593	0.00246	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—sarcoma	0.00059	0.00245	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—sarcoma	0.00058	0.0024	CcSEcCtD
Epinephrine—Haemoglobin—Epirubicin—sarcoma	0.000576	0.00239	CcSEcCtD
Epinephrine—Haemorrhage—Epirubicin—sarcoma	0.000573	0.00237	CcSEcCtD
Epinephrine—Hypoaesthesia—Epirubicin—sarcoma	0.00057	0.00236	CcSEcCtD
Epinephrine—Vomiting—Vincristine—sarcoma	0.00057	0.00236	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—sarcoma	0.000566	0.00235	CcSEcCtD
Epinephrine—ADRA2C—tendon—sarcoma	0.000557	0.0105	CbGeAlD
Epinephrine—Vomiting—Mitoxantrone—sarcoma	0.000555	0.0023	CcSEcCtD
Epinephrine—SLC22A5—tendon—sarcoma	0.000534	0.0101	CbGeAlD
Epinephrine—Haemoglobin—Doxorubicin—sarcoma	0.000533	0.00221	CcSEcCtD
Epinephrine—Nausea—Vincristine—sarcoma	0.000532	0.00221	CcSEcCtD
Epinephrine—Flushing—Epirubicin—sarcoma	0.000532	0.0022	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—sarcoma	0.00053	0.0022	CcSEcCtD
Epinephrine—CYP3A4—hematopoietic system—sarcoma	0.000529	0.01	CbGeAlD
Epinephrine—Hypoaesthesia—Doxorubicin—sarcoma	0.000527	0.00218	CcSEcCtD
Epinephrine—Nausea—Mitoxantrone—sarcoma	0.000519	0.00215	CcSEcCtD
Epinephrine—Arrhythmia—Epirubicin—sarcoma	0.000512	0.00212	CcSEcCtD
Epinephrine—ADRA2A—cardiac atrium—sarcoma	0.00051	0.00965	CbGeAlD
Epinephrine—ADRA2A—uterus—sarcoma	0.000507	0.0096	CbGeAlD
Epinephrine—Mental disorder—Epirubicin—sarcoma	0.000502	0.00208	CcSEcCtD
Epinephrine—Erythema—Epirubicin—sarcoma	0.000499	0.00207	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—sarcoma	0.000492	0.00204	CcSEcCtD
Epinephrine—Tension—Epirubicin—sarcoma	0.000489	0.00203	CcSEcCtD
Epinephrine—Nervousness—Epirubicin—sarcoma	0.000484	0.00201	CcSEcCtD
Epinephrine—Dizziness—Etoposide—sarcoma	0.00048	0.00199	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—sarcoma	0.000474	0.00196	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—sarcoma	0.000464	0.00192	CcSEcCtD
Epinephrine—Vomiting—Etoposide—sarcoma	0.000462	0.00191	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—sarcoma	0.000461	0.00191	CcSEcCtD
Epinephrine—ADRA2C—testis—sarcoma	0.000461	0.00873	CbGeAlD
Epinephrine—Agitation—Epirubicin—sarcoma	0.000458	0.0019	CcSEcCtD
Epinephrine—ADRA1A—liver—sarcoma	0.000458	0.00866	CbGeAlD
Epinephrine—Tension—Doxorubicin—sarcoma	0.000453	0.00188	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—sarcoma	0.000448	0.00186	CcSEcCtD
Epinephrine—ADRA2A—tendon—sarcoma	0.000445	0.00841	CbGeAlD
Epinephrine—SLC22A5—testis—sarcoma	0.000442	0.00836	CbGeAlD
Epinephrine—Palpitations—Epirubicin—sarcoma	0.000441	0.00183	CcSEcCtD
Epinephrine—ADRA2C—liver—sarcoma	0.000436	0.00825	CbGeAlD
Epinephrine—Nausea—Etoposide—sarcoma	0.000431	0.00179	CcSEcCtD
Epinephrine—Hypertension—Epirubicin—sarcoma	0.000431	0.00178	CcSEcCtD
Epinephrine—Chest pain—Epirubicin—sarcoma	0.000425	0.00176	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—sarcoma	0.000424	0.00176	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000422	0.00175	CcSEcCtD
Epinephrine—SLC22A5—liver—sarcoma	0.000418	0.0079	CbGeAlD
Epinephrine—Palpitations—Doxorubicin—sarcoma	0.000408	0.00169	CcSEcCtD
Epinephrine—Nervous system disorder—Epirubicin—sarcoma	0.000399	0.00165	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—sarcoma	0.000398	0.00165	CcSEcCtD
Epinephrine—Tachycardia—Epirubicin—sarcoma	0.000397	0.00165	CcSEcCtD
Epinephrine—Skin disorder—Epirubicin—sarcoma	0.000395	0.00164	CcSEcCtD
Epinephrine—Hyperhidrosis—Epirubicin—sarcoma	0.000393	0.00163	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—sarcoma	0.000393	0.00163	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00039	0.00162	CcSEcCtD
Epinephrine—CYP1A2—liver—sarcoma	0.000378	0.00716	CbGeAlD
Epinephrine—Nervous system disorder—Doxorubicin—sarcoma	0.000369	0.00153	CcSEcCtD
Epinephrine—Insomnia—Epirubicin—sarcoma	0.000368	0.00152	CcSEcCtD
Epinephrine—ADRA2A—testis—sarcoma	0.000368	0.00696	CbGeAlD
Epinephrine—Tachycardia—Doxorubicin—sarcoma	0.000368	0.00152	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—sarcoma	0.000366	0.00152	CcSEcCtD
Epinephrine—Paraesthesia—Epirubicin—sarcoma	0.000365	0.00151	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—sarcoma	0.000364	0.00151	CcSEcCtD
Epinephrine—Somnolence—Epirubicin—sarcoma	0.000362	0.0015	CcSEcCtD
Epinephrine—CYP2C9—liver—sarcoma	0.000359	0.00679	CbGeAlD
Epinephrine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000351	0.00146	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—sarcoma	0.000341	0.00141	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—sarcoma	0.000338	0.0014	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—sarcoma	0.000335	0.00139	CcSEcCtD
Epinephrine—ADRA2C—lymph node—sarcoma	0.000334	0.00632	CbGeAlD
Epinephrine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000325	0.00135	CcSEcCtD
Epinephrine—SLC22A5—lymph node—sarcoma	0.00032	0.00606	CbGeAlD
Epinephrine—CYP3A4—liver—sarcoma	0.000274	0.00518	CbGeAlD
Epinephrine—Dizziness—Epirubicin—sarcoma	0.000269	0.00111	CcSEcCtD
Epinephrine—ADRA2A—lymph node—sarcoma	0.000267	0.00505	CbGeAlD
Epinephrine—Vomiting—Epirubicin—sarcoma	0.000259	0.00107	CcSEcCtD
Epinephrine—Dizziness—Doxorubicin—sarcoma	0.000249	0.00103	CcSEcCtD
Epinephrine—Nausea—Epirubicin—sarcoma	0.000242	0.001	CcSEcCtD
Epinephrine—Vomiting—Doxorubicin—sarcoma	0.000239	0.000992	CcSEcCtD
Epinephrine—Nausea—Doxorubicin—sarcoma	0.000224	0.000927	CcSEcCtD
Epinephrine—ADRA2C—Hemostasis—KRAS—sarcoma	3.96e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IGF1R—sarcoma	3.93e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IGF1R—sarcoma	3.89e-05	0.000209	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—SRC—sarcoma	3.88e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IGF1R—sarcoma	3.84e-05	0.000206	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCR4—sarcoma	3.81e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MDM2—sarcoma	3.78e-05	0.000203	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—VEGFA—sarcoma	3.78e-05	0.000203	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ATF1—sarcoma	3.76e-05	0.000202	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—sarcoma	3.76e-05	0.000202	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—FOXO1—sarcoma	3.74e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2—sarcoma	3.74e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PDGFRB—sarcoma	3.73e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—NRAS—sarcoma	3.73e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2—sarcoma	3.73e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CREB1—sarcoma	3.72e-05	0.000199	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—FOXO1—sarcoma	3.71e-05	0.000199	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2—sarcoma	3.7e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PDGFRB—sarcoma	3.7e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HRAS—sarcoma	3.69e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PDGFRA—sarcoma	3.68e-05	0.000197	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—SRC—sarcoma	3.67e-05	0.000197	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—FOXO1—sarcoma	3.66e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2—sarcoma	3.66e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PDGFRB—sarcoma	3.65e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PDGFRA—sarcoma	3.64e-05	0.000195	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IGF1R—sarcoma	3.64e-05	0.000195	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO2—sarcoma	3.61e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—HRAS—sarcoma	3.6e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PDGFRA—sarcoma	3.6e-05	0.000193	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—HBA1—sarcoma	3.59e-05	0.000192	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF1R—sarcoma	3.58e-05	0.000192	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—VEGFA—sarcoma	3.58e-05	0.000192	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—NRAS—sarcoma	3.53e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—sarcoma	3.52e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HRAS—sarcoma	3.51e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FOXO1—sarcoma	3.46e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2—sarcoma	3.46e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PDGFRB—sarcoma	3.46e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CREB1—sarcoma	3.45e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FOXO1—sarcoma	3.41e-05	0.000183	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2—sarcoma	3.41e-05	0.000182	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PDGFRA—sarcoma	3.4e-05	0.000182	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PDGFRB—sarcoma	3.4e-05	0.000182	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KDR—sarcoma	3.4e-05	0.000182	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2—sarcoma	3.39e-05	0.000182	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2—sarcoma	3.38e-05	0.000181	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2—sarcoma	3.36e-05	0.00018	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—HRAS—sarcoma	3.36e-05	0.00018	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PDGFRA—sarcoma	3.35e-05	0.000179	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2—sarcoma	3.32e-05	0.000178	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCND1—sarcoma	3.29e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MYC—sarcoma	3.29e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—JUN—sarcoma	3.29e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CTNNB1—sarcoma	3.26e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EGFR—sarcoma	3.22e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—KRAS—sarcoma	3.21e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1R—sarcoma	3.18e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—sarcoma	3.14e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KIT—sarcoma	3.13e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—NRAS—sarcoma	3.13e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KDR—sarcoma	3.09e-05	0.000166	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—sarcoma	3.09e-05	0.000166	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO2—sarcoma	3.08e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KDR—sarcoma	3.07e-05	0.000164	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—HBA1—sarcoma	3.06e-05	0.000164	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PLCG1—sarcoma	3.06e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—KRAS—sarcoma	3.04e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FOXO1—sarcoma	3.03e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KDR—sarcoma	3.03e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—sarcoma	3.02e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PDGFRB—sarcoma	3.02e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CREB1—sarcoma	2.98e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PDGFRA—sarcoma	2.97e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1R—sarcoma	2.95e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—SRC—sarcoma	2.95e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—sarcoma	2.87e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KDR—sarcoma	2.86e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—sarcoma	2.86e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KIT—sarcoma	2.85e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—NRAS—sarcoma	2.85e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—EGFR—sarcoma	2.85e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NRAS—sarcoma	2.84e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KIT—sarcoma	2.82e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—NRAS—sarcoma	2.82e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KDR—sarcoma	2.82e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FOXO1—sarcoma	2.81e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—sarcoma	2.81e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PDGFRB—sarcoma	2.81e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KIT—sarcoma	2.79e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—NRAS—sarcoma	2.79e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PDGFRA—sarcoma	2.76e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—sarcoma	2.75e-05	0.000147	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—sarcoma	2.73e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CREB1—sarcoma	2.71e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—sarcoma	2.7e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—KRAS—sarcoma	2.69e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CREB1—sarcoma	2.69e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CREB1—sarcoma	2.65e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MYC—sarcoma	2.64e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KIT—sarcoma	2.64e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—NRAS—sarcoma	2.64e-05	0.000141	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PLCG1—sarcoma	2.62e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—sarcoma	2.6e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KIT—sarcoma	2.6e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—NRAS—sarcoma	2.6e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—sarcoma	2.58e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—sarcoma	2.58e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—sarcoma	2.57e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—sarcoma	2.55e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—sarcoma	2.54e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CREB1—sarcoma	2.51e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KDR—sarcoma	2.5e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CREB1—sarcoma	2.47e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MDM2—sarcoma	2.46e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—KRAS—sarcoma	2.45e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KRAS—sarcoma	2.44e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—KRAS—sarcoma	2.43e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—sarcoma	2.4e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—KRAS—sarcoma	2.4e-05	0.000129	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO2—sarcoma	2.38e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—sarcoma	2.37e-05	0.000127	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HBA1—sarcoma	2.36e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KDR—sarcoma	2.33e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KIT—sarcoma	2.31e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—NRAS—sarcoma	2.31e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—sarcoma	2.29e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—KRAS—sarcoma	2.27e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MDM2—sarcoma	2.24e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—KRAS—sarcoma	2.23e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MDM2—sarcoma	2.22e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—sarcoma	2.2e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MDM2—sarcoma	2.2e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CREB1—sarcoma	2.19e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—sarcoma	2.17e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—sarcoma	2.15e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KIT—sarcoma	2.14e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—NRAS—sarcoma	2.14e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—JUN—sarcoma	2.14e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CTNNB1—sarcoma	2.12e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—sarcoma	2.1e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—sarcoma	2.08e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MDM2—sarcoma	2.08e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—sarcoma	2.08e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—sarcoma	2.07e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MDM2—sarcoma	2.04e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—sarcoma	2.04e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CREB1—sarcoma	2.04e-05	0.000109	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLCG1—sarcoma	2.02e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—sarcoma	2.01e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—sarcoma	1.99e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	1.98e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—sarcoma	1.96e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—sarcoma	1.95e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	1.95e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—JUN—sarcoma	1.95e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—sarcoma	1.94e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CTNNB1—sarcoma	1.94e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—JUN—sarcoma	1.93e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—sarcoma	1.93e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SRC—sarcoma	1.92e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	1.92e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—sarcoma	1.91e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—JUN—sarcoma	1.91e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—sarcoma	1.9e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CTNNB1—sarcoma	1.89e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—sarcoma	1.87e-05	0.0001	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—sarcoma	1.86e-05	9.95e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—sarcoma	1.85e-05	9.9e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	1.84e-05	9.88e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—sarcoma	1.83e-05	9.79e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MDM2—sarcoma	1.82e-05	9.73e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—sarcoma	1.81e-05	9.7e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—JUN—sarcoma	1.81e-05	9.67e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	1.79e-05	9.6e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—sarcoma	1.78e-05	9.54e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—JUN—sarcoma	1.78e-05	9.52e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	1.76e-05	9.45e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SRC—sarcoma	1.75e-05	9.38e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SRC—sarcoma	1.73e-05	9.29e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—sarcoma	1.72e-05	9.22e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SRC—sarcoma	1.71e-05	9.17e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—sarcoma	1.7e-05	9.13e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—sarcoma	1.69e-05	9.05e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MDM2—sarcoma	1.69e-05	9.04e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	1.69e-05	9.04e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—sarcoma	1.68e-05	9.02e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—sarcoma	1.68e-05	9.02e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—sarcoma	1.67e-05	8.94e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—sarcoma	1.67e-05	8.93e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—sarcoma	1.65e-05	8.82e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—sarcoma	1.62e-05	8.69e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SRC—sarcoma	1.62e-05	8.68e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SRC—sarcoma	1.59e-05	8.54e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—sarcoma	1.59e-05	8.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—sarcoma	1.58e-05	8.48e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—JUN—sarcoma	1.58e-05	8.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—sarcoma	1.58e-05	8.45e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—sarcoma	1.57e-05	8.4e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	1.57e-05	8.4e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	1.57e-05	8.39e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—sarcoma	1.56e-05	8.35e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—sarcoma	1.55e-05	8.33e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—sarcoma	1.55e-05	8.32e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—sarcoma	1.53e-05	8.22e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—sarcoma	1.53e-05	8.22e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—sarcoma	1.53e-05	8.22e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—sarcoma	1.52e-05	8.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—sarcoma	1.51e-05	8.08e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—sarcoma	1.5e-05	8.04e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—sarcoma	1.47e-05	7.87e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—JUN—sarcoma	1.47e-05	7.86e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	1.46e-05	7.8e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—sarcoma	1.45e-05	7.78e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—sarcoma	1.45e-05	7.76e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—sarcoma	1.44e-05	7.69e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—sarcoma	1.43e-05	7.65e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—sarcoma	1.42e-05	7.61e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—sarcoma	1.42e-05	7.59e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SRC—sarcoma	1.42e-05	7.59e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—sarcoma	1.41e-05	7.57e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—sarcoma	1.4e-05	7.49e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	1.38e-05	7.39e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—sarcoma	1.36e-05	7.3e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—sarcoma	1.35e-05	7.24e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—sarcoma	1.34e-05	7.19e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—sarcoma	1.32e-05	7.07e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SRC—sarcoma	1.32e-05	7.05e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—sarcoma	1.29e-05	6.9e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	1.28e-05	6.87e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—sarcoma	1.28e-05	6.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—sarcoma	1.27e-05	6.8e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—sarcoma	1.27e-05	6.78e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—sarcoma	1.26e-05	6.75e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—sarcoma	1.24e-05	6.65e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—sarcoma	1.23e-05	6.6e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—sarcoma	1.22e-05	6.54e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—sarcoma	1.2e-05	6.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—sarcoma	1.19e-05	6.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—sarcoma	1.18e-05	6.32e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—sarcoma	1.17e-05	6.29e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—sarcoma	1.17e-05	6.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—sarcoma	1.15e-05	6.18e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—sarcoma	1.14e-05	6.11e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—sarcoma	1.12e-05	6.01e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—sarcoma	1.09e-05	5.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—sarcoma	1.04e-05	5.58e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—sarcoma	9.97e-06	5.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—sarcoma	9.68e-06	5.19e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—sarcoma	9.26e-06	4.96e-05	CbGpPWpGaD
